Handbook of Clinical medicine
KEYWORDS: patient, disease, patients, history, pain, heart, symptoms, ask, time, treatment, risk, examination, aortic, iinnddbb, pulse

27 We are hindered by publication bias. Around half of all clinical trials remain unpublished. See www.alltrials.net for the cam- paign to register all trials, and ensure methods and summary results are available. • Evidence can be expensive. Who paid the bill and what is their vested interest? • Is the result clinically signifi cant? What is the level of benefi t to the individual, as opposed to the population? Is the EBM tail wagging the clinical dog? • How is our innate hierarchy of evidence constructed? Do we maintain the same standard of the evidence for all changes to our practice? • Have you checked the correspondence columns in journals from which winning papers are extracted? It may take years for unforeseen fl aws to surface. • There is a danger that by always asking, ‘What is the evidence?’, we will divert resources from hard-to-prove areas (eg psychosocial interventions). • EBM is never 100% up to date and reworking meta-analyses takes time and mon- ey. Specialists may ostensibly reject a new trial due to a tiny fl aw, when the real dread is that it might fl ip their once-perfect formulation. • EBM lies uncomfortably in a world of
